Targeting of anti-cancer therapeutic agents by monoclonal antibodies.
Embleton
M J
MJ
D000818:Animals; D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002945:Cisplatin / Q000008:administration & dosage / Q000627:therapeutic use; D003630:Daunorubicin / Q000008:administration & dosage / Q000627:therapeutic use; D004304:Dosage Forms; D004317:Doxorubicin / Q000008:administration & dosage / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D051379:Mice; D012516:Osteosarcoma / Q000188:drug therapy; D012709:Serum Albumin; D014751:Vindesine / Q000008:administration & dosage / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D004304:Dosage Forms; D012709:Serum Albumin; D004317:Doxorubicin; D002945:Cisplatin; D014751:Vindesine; D008727:Methotrexate; D003630:Daunorubicin